Company Profile
Beijing Hony Biopharma Technology Co.,Ltd. is the high technology new-type enterprise which dedicates to pharmaceutical technology development and pharmaceutical technology transfer. Our main fields include technology development of pharmaceutical materials and intermediates, application and transfer of new projects, technical consultation and others. The company is located in Zhongguancun Science Park Daxing Bio-medicine Industry Park in Beijing. We take technology innovation as core, and collect many pharmaceutical exports, biological export, technical engineers and others in Beijing as the innovative team. We still own the young and specialization sale team with strong power. As the high technology enterprise with technology development, transfer and product sales, the company adheres to philosophy of stable thought to purse health to dedicate to research and development of pharmaceutical material and intermediate products for anti-virus, anti tumor, anti-depressant and others to provide foreign customers, and guarantees good product quality and better technical service.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
2,6-Dichloropurine-9-β-D-riboside |
2, 6-DICHLOROPURINE RIBOSIDE (2,6DClPR);2,6-Dichloropurine r;2,6-Dichloro-9-β-D-ribofuranosyl-9H-purine;2,6-dichloropuine nuceotide;(2R,3R,4S,5R)-2-(2,6-Dichloro-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol;2,6-dichloro-9-(β-D-ribofuranosyl)purine;2,6-Dichloro-9-(beta-D-ribofuranosyl)purine;2,6-Dichloropurine riboside###13276-52-3 |
13276-52-3 | Inquiry | |
2-Bromonicotinic acid |
2-Bromopyridine-3-carboxylic acid, 2-Bromo-3-carboxypyridine;2-Bromopyridine-3-carboxylic acid 97%;2-Bromopyridin-3-carboxylic acid;2-BROMOPYRIDINE-3-CARBOXYLIC ACID;2-BROMONICOTINIC ACID;2-BROMO-3-PYRIDINECARBOXYLIC ACID;AKOS BBS-00001340;3-PYRIDINECARBOXYLIC ACID, 2-BROMO- |
35905-85-2 | Inquiry | |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine |
1,2,4-Triazolo[4,3-a]pyrazine,5,6,7,8-tetrahydro-3-(trifluoromethyl)-;5,6,7,8-Tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine;3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine;3-Trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazine;5,6,7,8-Tetrahydro-3-(trifluoromethyl)-7H-[1,2,4]triazolo[4,3-a]pyrazine;3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazole[4,3-a]pyrazine;3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazol[4,3-a]pyrazine |
486460-21-3 | Inquiry | |
5-aminopyridine-3-carboxylic acid |
3-PYRIDINECARBOXYLIC ACID, 5-AMINO-;5-AMINO-3-PYRIDINECARBOXYLIC ACID;5-AMINOPYRIDINE-3-CARBOXYLIC ACID;5-AMINONICOTINIC ACID;AKOS BBS-00001362;IFLAB-BB F1926-0005;AURORA KA-3032;OTAVA-BB BB7017520056 |
24242-19-1 | Inquiry | |
Dapoxetine Hydrochloride |
DL-Dapoxteine HCL;N,N-DiMethyl-1-phenyl-3-(1-naphthalenyloxy)propanaMinehydrochloride;(S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride;D-(+)N,N-diMethyl-3-(naphthalen-1-yloxy);(αS)- N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-benzenemethanamine, hydrochloride (1:1);(6R,7R)-7-Amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidDapoxetine hydrochloride;Dapoxetine hydrochloride (1S)-N,N-Dimethyl-3-naphthalen-1-yloxy-1-phenyl-propan-1-amine hydrochloride;S-(+)-N,N-dimethyl-a-[2-(naphthalenyloxy)ethyl] benzenemethanamine hydrochloride, LY-210448 hydrochloride |
129938-20-1 | Inquiry | |
Raltegravir potassium |
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt;Raltegravir Potassium Salt;MK 0518;Raltegravir potassium;Raltegravir(MK-0518);Raltegravir K;Raltegravir-13C-d3;Raltegravir potassium, >=98% |
871038-72-1 | Inquiry |